Skip to Content
Merck
  • A fission yeast cell-based system for multidrug resistant HIV-1 proteases.

A fission yeast cell-based system for multidrug resistant HIV-1 proteases.

Cell & bioscience (2017-01-18)
Zsigmond Benko, Dong Liang, Ge Li, Robert T Elder, Anindya Sarkar, Jun Takayama, Arun K Ghosh, Richard Y Zhao
ABSTRACT

HIV-1 protease (PR) is an essential enzyme for viral production. Thus, PR inhibitors (PIs) are the most effective class of anti-HIV drugs. However, the main challenge to the successful use of PI drugs in patient treatment is the emergence of multidrug resistant PRs ( Three The three clinically isolated

MATERIALS
Product Number
Brand
Product Description

Supelco
1-Methylpyridinium iodide, analytical standard